These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 23237061)

  • 21. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.
    Vieta E; Valentí M
    CNS Drugs; 2013 Jul; 27(7):515-29. PubMed ID: 23749421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse prevention in bipolar disorder: a critical review of current guidelines.
    McAllister-Williams RH
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):12-6. PubMed ID: 16551667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating bipolar disorder. Evidence-based guidelines for family medicine.
    McIntyre RS; Mancini DA; Lin P; Jordan J
    Can Fam Physician; 2004 Mar; 50():388-94. PubMed ID: 15318676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment guidelines for bipolar disorder: a critical review.
    Fountoulakis KN; Vieta E; Sanchez-Moreno J; Kaprinis SG; Goikolea JM; Kaprinis GS
    J Affect Disord; 2005 May; 86(1):1-10. PubMed ID: 15820265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines for the biological treatment of bipolar depression].
    Samalin L; Charpeaud T; Guillaume S
    Encephale; 2011 Dec; 37 Suppl 3():S218-23. PubMed ID: 22212879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication treatment of bipolar disorder 2000: a summary of the expert consensus guidelines.
    Kahn DA; Sachs GS; Printz DJ; Carpenter D; Docherty JP; Ross R
    J Psychiatr Pract; 2000 Jul; 6(4):197-211. PubMed ID: 15990485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive treatment of acute mania: a clinical overview.
    Sachs GS; Gardner-Schuster EE
    Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision tree for the treatment of bipolar disorder.
    Sachs GS
    J Clin Psychiatry; 2003; 64 Suppl 8():35-40. PubMed ID: 12892540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bipolar depression: issues in diagnosis and treatment.
    Thase ME
    Harv Rev Psychiatry; 2005; 13(5):257-71. PubMed ID: 16251165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unmet clinical needs in bipolar disorder.
    Sachs GS
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S2-8. PubMed ID: 12832943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of bipolar depression: an update.
    Fountoulakis KN; Grunze H; Panagiotidis P; Kaprinis G
    J Affect Disord; 2008 Jul; 109(1-2):21-34. PubMed ID: 18037498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
    Schaffer A; McIntosh D; Goldstein BI; Rector NA; McIntyre RS; Beaulieu S; Swinson R; Yatham LN;
    Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.